The FDA has granted Priority Review to pegcetacoplan for the treatment of C3 glomerulopathy and primary immune complex membranoproliferative glomerulonephritis.

A research team has developed a compact peritoneal dialysis device that can be utilized as a portable artificial kidney. This ...